Dibenzoyl Thiamine
CAS No. 299-88-7
Dibenzoyl Thiamine( Bentiamine )
Catalog No. M21353 CAS No. 299-88-7
Dibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | Get Quote |
|
| 50MG | 27 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDibenzoyl Thiamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
-
DescriptionDibenzoyl Thiamine a lipophilic derivative of vitamin B (thiamine) is a kind of food additive.
-
In Vitro——
-
In Vivo——
-
SynonymsBentiamine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299-88-7
-
Formula Weight490.6
-
Molecular FormulaC26H26N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:98 mg/mL (199.76 mM)
-
SMILESCC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C
-
Chemical NameBenzenecarbothioic acid S-(2-(((4-amino-2-methyl-5-pyrimidinyl)methyl)formylamino)-1-(2-(benzoyloxy)ethyl)-1-propenyl) ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Heywood R Wood JD Majeed SK.Tumorigenic and toxic effect of OS-dibenzoyl thiamine hydrochloride in prolonged dietary administration to rats.Toxicol Lett. 1985 Jul;26(1):53-8
molnova catalog
related products
-
TIBI
TIBI is an ATP-competitive Rio1 inhibitor that acts in a similar manner to fungamycin and enhances the thermal stability of the enzyme.
-
C004019
C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for selective enhancement of tau ubiquitination and proteollyzation. C004019 is a candidate for AD and related tau protein diseases.
-
Atractylenolide III
Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.
Cart
sales@molnova.com